Related Experiment Videos

Characterization of a Mycobacterium smegmatis mutant lacking penicillin binding protein 1

H Billman-Jacobe1, R E Haites, R L Coppel

  • 1Department of Microbiology, Monash University, Clayton, Victoria 3168, Australia. Helen.BJ@med.monash.edu.au

Antimicrobial Agents and Chemotherapy
|December 3, 1999
PubMed

Insights

The ponA gene in Mycobacterium smegmatis creates penicillin-binding protein 1 (PBP1). Disrupting this gene made the bacteria sensitive to beta-lactams and grow slower.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • The ponA gene in Mycobacterium smegmatis encodes penicillin-binding protein 1 (PBP1).
  • PBP1 shares similarities with PBP1s found in Mycobacterium tuberculosis and Mycobacterium leprae.
  • Understanding PBP1's function is crucial for developing new antimicrobial strategies.

Purpose of the Study:

  • To investigate the function of the ponA gene and its encoded PBP1 in Mycobacterium smegmatis.
  • To characterize the phenotypic changes in a PBP1-deficient mutant.

Main Methods:

  • Transposon mutagenesis was used to create a PBP1-deficient mutant of Mycobacterium smegmatis.
  • Phenotypic analysis included assessing sensitivity to beta-lactam antibiotics and permeability to glycine.
  • Growth rates were monitored in liquid culture.

Main Results:

  • Disruption of the ponA gene successfully generated a PBP1-deficient mutant.
  • The mutant exhibited increased sensitivity to beta-lactam antibiotics.
  • The PBP1-deficient mutant showed enhanced permeability to glycine and a reduced growth rate in liquid culture.

Conclusions:

  • PBP1 plays a significant role in the cell wall integrity and antibiotic resistance of Mycobacterium smegmatis.
  • Targeting PBP1 could be a viable strategy for combating Mycobacterium infections.
  • Further research into PBP1 function may reveal novel therapeutic targets.

Related Concept Videos